Society guideline links: Hypoglycemia in adults

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Diabetes mellitus in adults".)

International

●Endocrine Society (ES): Clinical practice guideline for the management of individuals with diabetes at high risk for hypoglycemia (2022)

●American Diabetes Association (ADA) and ES: Consensus statement on hypoglycemia and diabetes – A report (2013)

Canada

●Diabetes Canada: Clinical practice guidelines

•Hypoglycemia in adults, update (2023)

•Monitoring glycemic control (2018)

•Targets for glycemic control (2018)

●Choosing Wisely Canada: Avoid using medications known to cause hypoglycemia to achieve hemoglobin A1c <7.5 percent in many adults age 65 and older; moderate control is generally better (2022)

●Choosing Wisely Canada: Don't recommend routine or multiple daily self-glucose monitoring in adults with stable type 2 diabetes on agents that do not cause hypoglycemia (2020)

United States

●American Diabetes Association (ADA): Standards of care in diabetes (2025)

•Glycemic goals and hypoglycemia

•Pharmacologic approaches to glycemic treatment

●ADA and Endocrine Society (ES): Consensus statement on hypoglycemia and diabetes – A report (2013)

United Kingdom

●Joint British Diabetes Societies for Inpatient Care (JBDS-IP): Clinical guideline for the hospital management of hypoglycemia in adults with diabetes mellitus (revised 2023)

●Association of Anaesthetists of Great Britain and Ireland (AAGBI): Safety guideline on arterial line blood sampling – Preventing hypoglycaemic brain injury (2014)

Australia–New Zealand

●Choosing Wisely Australia: Avoid multiple daily glucose self-monitoring in adults with stable type 2 diabetes on agents that do not cause hypoglycaemia (2015)